Polatuzumab vedotin for treating relapsed or refractory diffuse large B-cell lymphoma

Agency for Care Effectiveness (ACE)
Record ID 32018002614
English
Details
Project Status: Completed
Year Published: 2022
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Singapore
MeSH Terms
  • Lymphoma, Large B-Cell, Diffuse
  • Antibodies, Monoclonal
  • Immunoconjugates
  • Antineoplastic Agents, Immunological
Contact
Organisation Name: Agency for Care Effectiveness (ACE)
Contact Address: Ministry of Health, College of Medicine Building, 16 College Road, Singapore 169854
Contact Name: ACE_HTA@moh.gov.sg
Contact Email: ACE_HTA@moh.gov.sg
Copyright: Agency for Care Effectiveness (ACE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.